SignatureFD’s BlackRock ESG Capital Allocation Term Trust ECAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$219 Buy
14
+1
+8% +$15 ﹤0.01% 3410
2026
Q1
$180 Hold
13
﹤0.01% 3374
2025
Q4
$193 Buy
13
+1
+8% +$16 ﹤0.01% 3302
2025
Q3
$195 Buy
12
+1
+9% +$16 ﹤0.01% 3280
2025
Q2
$181 Hold
11
﹤0.01% 3177
2025
Q1
$168 Sell
11
-508
-98% -$8.4K ﹤0.01% 3253
2024
Q4
$8.51K Buy
+519
New +$9.01K ﹤0.01% 2424
2022
Q2
Sell
-12,717
Closed -$212K 3163
2022
Q1
$212K Buy
12,717
+217
+2% +$3.67K 0.01% 697
2021
Q4
$233K Hold
12,500
0.01% 657
2021
Q3
$251K Buy
+12,500
New +$251K 0.01% 599

Other funds holding ECAT

SignatureFD's ECAT Position: Q2 2026 in Review

SignatureFD increased its BlackRock ESG Capital Allocation Term Trust (ECAT) stake by 7.7% in Q2 2026, buying an estimated $15 and bringing the position to 14 shares worth $219. The position accounts for ﹤0.01% of the portfolio, ranked #3410.

SignatureFD first reported a position in ECAT in Q3 2021 and has held it in 10 quarters since. The position peaked at $251K in Q3 2021. 79 funds tracked by Wall St. Rank hold ECAT as of Q2 2026.

  • SignatureFD held 14 shares of BlackRock ESG Capital Allocation Term Trust worth $219 as of Q2 2026.
  • SignatureFD bought 1 BlackRock ESG Capital Allocation Term Trust share in Q2 2026, an estimated $15.
  • BlackRock ESG Capital Allocation Term Trust made up ﹤0.01% of SignatureFD's portfolio in Q2 2026, its #3410 holding.
  • SignatureFD first reported a position in BlackRock ESG Capital Allocation Term Trust in Q3 2021 and has held it in 10 quarters since.
  • SignatureFD's BlackRock ESG Capital Allocation Term Trust position peaked at $251K in Q3 2021.
  • 79 funds tracked by Wall St. Rank held BlackRock ESG Capital Allocation Term Trust as of Q2 2026.

Based on SignatureFD's 13F filing for Q2 2026, filed 24 Jul 2026.